Ali Hazazi

Ali Hazazi

Auto-generated profile, based on publicly available information

Ali Hazazi

Department of Pathology and Laboratory Medicine, Security Forces Hospital Program, Riyadh, Saudi Arabia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
MHMohammed Ageeli Hakami
Mohammed Ageeli Hakami
AHAli Hazazi
Ali Hazazi
OAOsama Abdulaziz
Osama Abdulaziz
HAHassan Hussain Almasoudi
Hassan Hussain Almasoudi
AAAbdulfattah Yahya M Alhazmi
Abdulfattah Yahya M Alhazmi
FKFarhan R. Khan
Farhan R. Khan

19 November 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMuhammed Shabil
Muhammed Shabil
SGShilpa Gaidhane
Shilpa Gaidhane
SBSuhas Ballal
Suhas Ballal
SKSanjay Kumar
Sanjay Kumar
MBMahakshit Bhat
Mahakshit Bhat
GSGajendra Sharma
Gajendra Sharma
The COVID-19 pandemic has significantly impacted public health, with emerging evidence suggesting substantial effects on maternal and neonatal health. This systematic review and meta-analysis aimed to quantify the prevalence and risk of respiratory distress syndrome (RDS) in newborns born to mothers infected with SARS-CoV-2, the virus responsible for COVID-19. We conducted a literature search in Embase, PubMed, and Web of Science up to April 20, without language or date restrictions. Observational studies reporting on the prevalence or risk of RDS among newborns from mothers with confirmed SARS-CoV-2 infection were included. Quality assessment was performed using the JBI tool. Statistical analysis was performed by using R software version 4.3. Twenty-two studies met the inclusion criteria. The pooled prevalence of RDS among newborns born to COVID-19-infected mothers was 11.5% (95% CI: 7.4–17.3%), with significant heterogeneity (I² = 93%). Newborns from infected mothers had a significantly higher risk of developing RDS, with a pooled risk ratio (RR) of 2.69 (95% CI: 1.77 to 4.17). Newborns born to mothers with COVID-19 have a substantially increased risk of developing RDS. These findings emphasize the need for vigilant monitoring and appropriate management of pregnant women with COVID-19 to mitigate adverse neonatal outcomes.

Verified
Journal Article
Open access
PDF file
AAAbdulraheem Almalki
Abdulraheem Almalki
ASAlaa Shafie
Alaa Shafie
AHAli Hazazi
Ali Hazazi
HBHamsa J. Banjer
Hamsa J. Banjer
MBMaha Mahfouz Bakhuraysah
Maha Mahfouz Bakhuraysah
Farah AnjumFarah Anjum
Farah Anjum
Cathepsin L (CTSL) expression is dysregulated in a variety of cancers. Extensive empirical evidence indicates their direct participation in cancer growth, angiogenic processes, metastatic dissemination, and the development of treatment resistance. Currently, no natural CTSL inhibitors are approved for clinical use. Consequently, the development of novel CTSL inhibition strategies is an urgent necessity. In this study, a combined machine learning (ML) and structure-based virtual screening strategy was employed to identify potential natural CTSL inhibitors. The random forest ML model was trained on IC50 values. The accuracy of the trained model was over 90%. Furthermore, we used this ML model to screen the Biopurify and Targetmol natural compound libraries, yielding 149 hits with prediction scores >0.6. These hits were subsequently selected for virtual screening using a structure-based approach, yielding 13 hits with higher binding affinity compared to the positive control (AZ12878478). Two of these hits, ZINC4097985 and ZINC4098355, have been shown to strongly bind CTSL proteins. In addition to drug-like properties, both compounds demonstrated high affinity, ligand efficiency, and specificity for the CTSL binding pocket. Furthermore, in molecular dynamics simulations spanning 200 ns, these compounds formed stable protein-ligand complexes. ZINC4097985 and ZINC4098355 can be considered promising candidates for CTSL inhibition after experimental validation, with the potential to provide therapeutic benefits in cancer management.

31 May 2024 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
BABADER Saud ALOTAIBI
BADER Saud ALOTAIBI
MHMohammed Ageeli Hakami
Mohammed Ageeli Hakami
AHAli Hazazi
Ali Hazazi
AAAhad Amer Alsaiari
Ahad Amer Alsaiari
MKMohammad Khalid
Mohammad Khalid
ABAnam Beg
Anam Beg
Interleukin-8 (IL-8) is a chemokine, a type of signaling molecule that has a role in immunological responses and inflammation. In recent years, IL-8 is additionally related to cancer growth and recurrence. Breast cancer growth, progression, and metastatic development are all linked to IL-8. Breast cancer cells are known to develop faster when IL-8 stimulates their proliferation and survival. It can also cause angiogenesis, or the creation of new blood vessels, which is necessary for tumor nutrition and growth. IL-8 and curcumin have been subjects of interest in drug design, particularly in the context of inflammation-related disorders and cancer. This study aims to give an overview of the role of IL-8. Inhibitor-based treatment approaches were being used to target IL-8 with curcumin. Molecular docking method was employed to find a potential interaction to supress competitive inhibition of IL-8 with curcumin. PASS analysis and ADMET characteristics were also being carried out. In the end, IL-8 complexed with curcumin is chosen for MD simulations. Overall, our results showed that during the simulation, the complex stayed comparatively stable. It is also possible to investigate curcumin further as a possible treatment option. The combined results imply that IL-8 and their genetic alterations can be studied in precision cancer therapeutic treatments, utilizing target-driven therapy and early diagnosis.

25 July 2024 in Computation
Verified
Journal Article
Open access
PDF file
Farah AnjumFarah Anjum
Farah Anjum
AHAli Hazazi
Ali Hazazi
FAFouzeyyah Ali Alsaeedi
Fouzeyyah Ali Alsaeedi
MBMaha Mahfouz Bakhuraysah
Maha Mahfouz Bakhuraysah
ASAlaa Shafie
Alaa Shafie
MNMaryam Ishrat Niaz
Maryam Ishrat Niaz
Clostridium histolyticum is a Gram-positive anaerobic bacterium belonging to the Clostridium genus. It produces collagenase, an enzyme involved in breaking down collagen which is a key component of connective tissues. However, antimicrobial resistance (AMR) poses a great challenge in combating infections caused by this bacteria. The lengthy nature of traditional drug development techniques has resulted in a shift to computer-aided drug design and other modern drug discovery approaches. The above method offers a cost-effective means for gathering comprehensive information about how ligands interact with their target proteins. The objective of this study is to create novel, explicit drugs that specifically inhibit the C. histolyticum collagenase enzyme. Through structure-based virtual screening, a library containing 1830 compounds was screened to identify potential drug candidates against collagenase enzymes. Following that, molecular dynamic (MD) simulation was performed in an aqueous solution to evaluate the behavior of protein and ligand in a dynamic environment while density functional theory (DFT) analysis was executed to predict the molecular properties and structure of lead compounds, and the WaterSwap technique was utilized to obtain insights into the drug–protein interaction with water molecules. Furthermore, principal component analysis (PCA) was performed to reveal conformational changes, salt bridges to express electrostatic interaction and protein stability, and absorption, distribution, metabolism, excretion, and toxicity (ADMET) to assess the pharmacokinetics profile of top compounds and control molecules. Three potent drug candidates were identified MSID000001, MSID000002, MSID000003, and the control with a binding score of −10.7 kcal/mol, −9.8 kcal/mol, −9.5 kcal/mol, and −8 kcal/mol, respectively. Furthermore, Molecular Mechanics Poisson–Boltzmann Surface Area (MMPBSA) analysis of the simulation trajectories revealed energy scores of −79.54 kcal/mol, −73.99 kcal/mol, −62.26 kcal/mol, and −70.66 kcal/mol, correspondingly. The pharmacokinetics properties exhibited were under the acceptable range. The compounds hold the potential to be novel drugs; therefore, further investigation needs to be conducted to find out their anti-collagenase action against C. histolyticum infections and antibiotic resistance.

1 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
S.Sadaf ..
Sadaf ..
AHAli Hazazi
Ali Hazazi
SASamia S. Alkhalil
Samia S. Alkhalil
AAAhad Amer Alsaiari
Ahad Amer Alsaiari
AAAhmad El Askary
Ahmad El Askary
KDKapil Dev
Kapil Dev
Breast cancer has been acknowledged as one of the most notorious cancers, responsible for millions of deaths around the globe. Understanding the various factors, genetic mutations, comprehensive pathways, etc., that are involved in the development of breast cancer and how these affect the development of the disease is very important for improving and revitalizing the treatment of this global health issue. The forkhead-box gene family, comprising 19 subfamilies, is known to have a significant impact on the growth and progression of this cancer. The article looks into the various forkhead genes and how they play a role in different types of cancer. It also covers their impact on cancer drug resistance, interaction with microRNAs, explores their potential as targets for drug therapies, and their association with stem cells.